Elisa Giommoni

HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research

Filippo Pietrantonio, M. Caporale, Federica Morano et al. · International Journal of Cancer · 2016 · 149 citations · Full text

Medicine, Cancer Biology, Oncology +13

Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study

Filippo Pietrantonio, Giovanni Fucà, Federica Morano et al. · Clinical Cancer Research · 2017 · 109 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey

Nicola Silvestris, Francesco Pantano, Toni Ibrahim et al. · PLoS ONE · 2013 · 67 citations · Full text

Medicine, Oncology, Surgery +15

Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

Agnese Paderi, Roberta Giorgione, Elisa Giommoni et al. · Cancers · 2021 · 64 citations · Full text

Medicine, Immunology, Oncology +17

hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications

Olivia Crociani, Elena Lastraioli, Luca Boni et al. · Clinical Cancer Research · 2014 · 55 citations · Full text

Medicine, Cell Biology, Oncology +17